Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biophytis Sa ADR (NQ: BPTS )

2.370 -0.010 (-0.42%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 793
Open 2.340
Bid (Size) 2.220 (1)
Ask (Size) 2.370 (1)
Prev. Close 2.380
Today's Range 2.340 - 2.390
52wk Range 2.260 - 15.40
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biophytis has Filed with the French National Authority for Health (HAS) an Application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19
Via ACCESSWIRE
Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
Via ACCESSWIRE

Performance

YTD
-47.32%
-47.32%
1 Month
-32.48%
-32.48%
3 Month
-62.32%
-62.32%
6 Month
-43.58%
-43.58%
1 Year
-79.21%
-79.21%

More News

Read More
Biophytis has Filed with the EMA for Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Successful Capital Increase for Biophytis with €2.3 million Raised
Via ACCESSWIRE
Biophytis Launches a Round of Fundraising for Approximately 2 Million Euros
Via ACCESSWIRE
Biophytis has Requested a Pre-Submission Meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the Treatment of COVID-19
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Biophytis Strengthens its Management Team
Via ACCESSWIRE
Biophytis Announces Receipt of Nasdaq Notice
Via ACCESSWIRE
Biophytis Regains Compliance with NASDAQ Minimum Bid Price Requirement
Via ACCESSWIRE
Biophytis Announces 2022 Financial Results and 2023 Perspectives
Via ACCESSWIRE
Biophytis: Results of the Combined General Meeting on April 17, 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Biophytis: The Combined General Meeting Will Be Held on Second Call on April 17, 2023
Via ACCESSWIRE
Roku Layoffs 2023: What to Know About the Latest ROKU Job Cuts
Via InvestorPlace
Why Is Semtech (SMTC) Stock Down 21% Today?
Via InvestorPlace
Why Is Biophytis (BPTS) Stock On The Move Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Biophytis: Biophytis Presented Sarconeos (BIO101) As A Possible Treatment Candidate for Long COVID After Hospitalization During The 13th Annual International Conference on Frailty and Sarcopenia Resea
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program
Via ACCESSWIRE
Why JD.com Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.